2024 Annual Meeting | C141 - Rapidly Progressive Dementia

Date Tuesday 04/16/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | Bluebird 1C

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Gregory S. Day, MD, MSc, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the common causes and clinical features of rapidly progressive dementia, be able to apply sensitive and specific tests to accurately diagnose patients with specific causes of rapidly progressive dementia, and be able to recognize the clinical and paraclinical findings that suggest a potentially reversible cause of rapidly progressive dementia.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM MDT	Speaker	Approach to RPD Gregory S. Day, MD, MSc, FAAN
04:00 PM - 04:25 PM MDT	Speaker	Creutzfeldt-Jakob Disease Valerie Sim, MD, BSc
04:25 PM - 04:50 PM MDT	Speaker	Recognizing Treatment Responsive Causes of RPD Gregory S. Day, MD, MSc, FAAN
04:50 PM - 05:20 PM MDT	Speaker	RPD Cases (Interactive Discussion) Gregory S. Day, MD, MSc, FAAN, Valerie Sim, MD, BSc
05:20 PM - 05:30 PM MDT	Q&A	Questions & Answers Gregory S. Day, MD, MSc, FAAN, Valerie Sim, MD, BSc

Faculty Disclosures
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Valerie Sim, MD, BSc	The institution of Dr. Sim has received research support from the CJD Foundation. The institution of Dr. Sim has received research support from National Research Council of Canada Nanotechnology Research Centre. Dr. Sim has received intellectual property interests from a discovery or technology relating to health care.